tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

KRYS Stock Latest News

Hold Rating Maintained Amid Mixed Market Performance and Future Pipeline Potential
RatingsHold Rating Maintained Amid Mixed Market Performance and Future Pipeline Potential
5h ago
KRYS
Krystal Biotech price target raised to $198 from $166 at Citi
PremiumThe Fly
Krystal Biotech price target raised to $198 from $166 at Citi
5h ago
KRYS
Krystal Biotech Reports Strong Q3 2025 Performance
PremiumCompany Announcements
Krystal Biotech Reports Strong Q3 2025 Performance
13h ago
KRYS
Krystal Biotech’s Strong Financial Performance and Strategic Initiatives Justify Buy Rating
PremiumRatings
Krystal Biotech’s Strong Financial Performance and Strategic Initiatives Justify Buy Rating
14h ago
KRYS
Krystal Biotech price target raised to $220 from $216 at Chardan
PremiumThe Fly
Krystal Biotech price target raised to $220 from $216 at Chardan
16h ago
KRYS
Positive Outlook for Krystal Biotech: Growth Potential Driven by Vyjuvek, Clinical Pipeline, and Global Expansion
PremiumRatingsPositive Outlook for Krystal Biotech: Growth Potential Driven by Vyjuvek, Clinical Pipeline, and Global Expansion
16h ago
KRYS
Krystal Biotech price target raised to $217 from $212 at Clear Street
Premium
The Fly
Krystal Biotech price target raised to $217 from $212 at Clear Street
22h ago
KRYS
Krystal Biotech sees FY25 non-GAAP R&D, SG&A expense $145M-$155M
Premium
The Fly
Krystal Biotech sees FY25 non-GAAP R&D, SG&A expense $145M-$155M
1d ago
KRYS
Krystal Biotech reports Q3 EPS $2.66, consensus $1.12
PremiumThe Fly
Krystal Biotech reports Q3 EPS $2.66, consensus $1.12
1d ago
KRYS
KRYS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
KRYS Earnings this Week: How Will it Perform?
3d ago
KRYS
Krystal Biotech’s Promising Lung Cancer Study: A Potential Game-Changer?
PremiumCompany Announcements
Krystal Biotech’s Promising Lung Cancer Study: A Potential Game-Changer?
8d ago
KRYS
Krystal Biotech’s KB407 Study: A Promising Step for Cystic Fibrosis Treatment
PremiumCompany Announcements
Krystal Biotech’s KB407 Study: A Promising Step for Cystic Fibrosis Treatment
8d ago
KRYS
Krystal Biotech’s Innovative Approach to Treating Alpha-1 Antitrypsin Deficiency: A Clinical Update
PremiumCompany AnnouncementsKrystal Biotech’s Innovative Approach to Treating Alpha-1 Antitrypsin Deficiency: A Clinical Update
8d ago
KRYS
Krystal Biotech Advances DEB Research with New Observational Study
Premium
Company Announcements
Krystal Biotech Advances DEB Research with New Observational Study
8d ago
KRYS
Krystal Biotech’s Promising Study on KB803 for DEB: A Potential Game Changer?
Premium
Company Announcements
Krystal Biotech’s Promising Study on KB803 for DEB: A Potential Game Changer?
8d ago
KRYS
Krystal Biotech’s Promising Study on KB801 for Neurotrophic Keratitis: Market Implications
PremiumCompany Announcements
Krystal Biotech’s Promising Study on KB801 for Neurotrophic Keratitis: Market Implications
8d ago
KRYS
Krystal Biotech’s KB707 Study: A New Hope for Advanced Cancer Treatment
PremiumCompany Announcements
Krystal Biotech’s KB707 Study: A New Hope for Advanced Cancer Treatment
8d ago
KRYS
Krystal Biotech Launches VYJUVEK® in Japan
PremiumCompany Announcements
Krystal Biotech Launches VYJUVEK® in Japan
13d ago
8K
KRYS
Krystal Biotech price target raised to $224 from $189 at Guggenheim
PremiumThe Fly
Krystal Biotech price target raised to $224 from $189 at Guggenheim
18d ago
KRYS
Krystal Biotech price target raised to $255 from $182 at BofA
PremiumThe FlyKrystal Biotech price target raised to $255 from $182 at BofA
18d ago
KRYS
Krystal Biotech gets FDA platform technology designation to HSV-1 viral vector
Premium
The Fly
Krystal Biotech gets FDA platform technology designation to HSV-1 viral vector
21d ago
KRYS
Krystal Biotech’s Growth Potential Bolstered by FDA Approval and Promising Pipeline Developments
Premium
Ratings
Krystal Biotech’s Growth Potential Bolstered by FDA Approval and Promising Pipeline Developments
2M ago
KRYS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >